[Pharmwaste] Request for legislataive support

gressitt at uninets.net gressitt at uninets.net
Thu May 10 09:14:45 EDT 2007



DATE: MAY 11, 2007

TO: 	TO ALL MEMBERS OF THE MAINE BENZODIAZEPINE STUDY GROUP LIST SERV

FROM: STEVAN GRESSITT, M.D.

RE: 	A SPECIAL ALERT TO COLLEAGUES AND AN URGENT REQUEST FOR SUPPORT

________________________________________________________________________
____
__________________________________________________________________

On Wednesday, May 16th, in Room 228 of the Maine Statehouse, LD 411 , An
Act To Establish a Pilot Program for Return of Unused Prescription Drugs
by Mail will be heard.

Building on previous legislation in Maine which was the first of its
kind in the United States, LD 411 request funds from the State of Maine
to implement a expired drug take-back program which to date has been
enacted but not funded. LD 411 will build on research resulting from
previous prescription take-backs in the State of Maine and elsewhere in
the United States. The link to the legislative page is found below:


Unused Medicine LD  Representative Anne Perry
http://janus.state.me.us/legis/LawMakerWeb/summary.asp?ID=280022859




Your help is urgently requested! Your letter of support for this
legislation can help strengthen our case . Points to consider in
preparing your letters of support include:


1. Medicare Part D has had the unintended consequence of  blocking the
return of unused medications from those users previous covered by other
programs. These drugs, valued in the millions of dollars, are now either
being disposed of by flushing or are now prone to misuse and diversion.

2. There is currently an inability to capture systematic data that could
promote patient compliance and guard against inappropriate disposal in
the trash.

3. There is currently an inability to provide feedback to prescribers of
those drugs that are most likely to be subject to patient non-compliance
or early discontinuation.

4. The development of  both state and national unused medicine disposal
policy will be best accomplished using systematically collected data
rather than anectdotal information.

5. Development of a program funded by the State permits identification
of costs instructive in the future identification of potential funding
sources for such a program.

6. The state and the public would benefit from open discussion of the
data that this program will produce.

7. Identification of discarded medication holds the potential for
encouraging post-market compliance.

8. Identification of controlled drug returns may assist with planning
for prescription drug abuse reduction.

9. Each returned pill represents one less pill available for misuse and
abuse.


Please feel free to approach this subject from your own perspective, not
necessarily focusing on any of the points noted above.

The sponsor of the legislation, Representative Anne Perry, requests the
opportunity to see these letters prior to the hearing, so I have agreed
to have them come to me so copies can be made in time and forwarded for
distribution to the Committee on Appropriations and Financial Affairs.
In order for me to do this I will need them at the latest by Tuesday 9
am (EST). Please email your letters directly to gressitt at gmail.com. If
you wish, they may also be mailed directly to the Appropriations
Committee at the address below (if you wish to do this 20 copies are
needed).


All letters of support should be addressed as follows:

Senator Margaret Rotundo, Chair
Representative Jeremy R. Fischer, Chair
Members of the Committee on Appropriations and Financial Affairs
5 State House Station
Augusta, ME
04333-0005

YOUR WILLINGNESS TO ACT QUICKLY COULD MAKE THE DIFFERENCE! PLEASE HELP!

THANK YOU VERY MUCH!





Confidentiality Notice: The information contained in this electronic
communication, and any electronic attachments(s), is CONFIDENTIAL and is
for the sole use of the intended individual, even if addressed
incorrectly.  This transmission may contain privileged and confidential
information.  This information is for use only by the person(s) or entity
to whom it pertains.  If you have received this message in error, or are
not the named recipient(s), please immediately notify the sender via reply
email and delete this communication.  You are hereby notified that any
release of information or distribution of this communication is
prohibited. Thank you for your compliance.





More information about the Pharmwaste mailing list